We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 20, 2020

Current Use and Safety of Novel Oral Anticoagulants in Adults With Congenital Heart Disease

European Heart Journal

 

Additional Info

European Heart Journal
Current Use and Safety of Novel Oral Anticoagulants in Adults With Congenital Heart Disease: Results of a Nationwide Analysis Including More Than 44 000 Patients
Eur Heart J 2020 Nov 13;[EPub Ahead of Print], E Freisinger, J Gerß, L Makowski, U Marschall, H Reinecke, H Baumgartner, J Koeppe, GP Diller

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading